Summary
The use of calcium (Ca) supplements by postmenopausal women is growing rapidly. A commercial preparation of tricalcium phosphate (TCP) is available in the USA. Depending on the relative absorption of Ca versus phosphate, a rise in serum phosphorus (P) could stimulate parathyroid hormone (iPTH) secretion. We therefore compared Ca absorption and the metabolic responses following TCP to that of Ca carbonate (CC) on separate occasions in each of 10 women, aged 22–40 years. The subjects were fasted overnight for 12 hours while good hydration was maintained. Following a 2-hour baseline-urine collection, 1200 mg calcium (as CC or TCP) was ingested and two 2-hour postload urine collections were made. Blood was drawn at 1, 2, and 4 hours after the Ca load. Serum (S) and urine (U) Ca, P, and creatinine, and U cyclic AMP (cAMP) were determined. iPTH levels following TCP were also measured. Ca absorption was determined by the postload rise in Uca above baseline. Uca excretion increased significantly and was accompanied by significant rises in Sca after both preparations. Following TCP, S and U phosphorus increased. Urinary cAMP did not change after either preparation, and iPTH levels fell after oral TCP. We conclude that Ca taken as TCP is absorbed adequately and, thus, despite a rise in the S phosphorus level does not stimulate parathyroid activity.
Similar content being viewed by others
References
Peck WA, Riggs BL, Bell NH, Wallace RB, Johnston Jr CC, Gordon SL, Shulman LE (1988) Research directions in osteoporosis. Am J Med 84:275–282
Heaney RP (1987) Bioavailability of calcium. Bol Asoc Med PR. 79:27–29
Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive resorptive and renal hypercalciurias. N Engl J Med 292:497–500
Broadus AE, Dominguez M, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria—use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760
Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E (1975) Metabolism of immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest 56:39–48
Wilkinson R (1976) Absorption of calcium, phosphorus and magnesium. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Churchill-Livingstone, New York, 36–112
Nicar MJ, Pak CYC (1985) Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab 61:391–393
Reid IR, Schooler BA, Hannan SF, Ibbertson HK (1986) The acute biochemical effects of four proprietary calcium preparations. Aust NZ J Med 16:193–197
Aurbach GD, Marx SJ, Spiegel AM (1975) Parathyroid hormone, calcitonin, and the calciferols In: Wilson JD, Foster DW (eds). Williams textbook of endocrinology 7th ed. WB Saunders, Philadelphia, pp 1137–1217
Kerr C, Loken HF, Glendening MB, Gordan GS, Page EW (1962) Calcium and phosphorus dynamics in pregnancy Am J Obst Gynecol 83:1–8
Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL (1970) The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 49:2146–2149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shires, R., Kessler, G.M. The absorption of tricalcium phosphate and its acute metabolic effects. Calcif Tissue Int 47, 142–144 (1990). https://doi.org/10.1007/BF02555978
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02555978